Business of Optometry

Top Story

Zeiss appoints Jim Mazzo as global president of ophthalmology

Zeiss appoints Jim Mazzo as global president of ophthalmology
July 27, 2016

Carl Zeiss Meditec appointed James V. Mazzo as global president of ophthalmology, according to a company press release.

In this role, Mazzo will be responsible for leading the new strategic business unit of ophthalmology and the company’s U.S. sales and service center.

TANZANITE study: No re-treatments required with triamcinolone acetonide formulation after 3 months

July 27, 2016
A majority of patients treated with a proprietary form of triamcinolone acetonide in combination with aflibercept required no additional treatments over 3 months…

July’s top five FDA news stories in ophthalmology

July 26, 2016
July’s hot topics in ophthalmology ranged from long-awaited FDA approvals including Shire’s lifitegrast ophthalmic solution for dry eye disease to…

FDA raises concerns about manufacturing deficiencies in Dextenza complete response letter

July 25, 2016
Ocular Therapeutix received a complete response letter from the FDA regarding the new drug application for Dextenza for the treatment of postoperative ocular pain…
In the Journals

Macular carotenoids can have positive effects on visual function

July 19, 2016
Researchers found that in subjects free of retinal disease and with low macular pigment, supplementation with a…
More »
Meeting News Coverage

Latanoprostene bunod reduces IOP, ocular hypertension

July 20, 2016
BOSTON – Once daily latanoprostene bunod 0.024%, taken in the evening, reduced IOP in subjects with open angle…
More »
Featured
Optometry's Meeting 2016

Optometry's Meeting 2016

Perspectives on Glaucoma

Study: Perimetry detects progression before photography in eyes with field loss

July 21, 2016
Progression in the visual field was detected first, more than four times as often as progression in the optic disc, in…
More »

Zeiss appoints Jim Mazzo as global president of ophthalmology

July 27, 2016
Carl Zeiss Meditec appointed James V. Mazzo as global president of ophthalmology, according to a company press release. In this role, Mazzo will be…

TANZANITE study: No re-treatments required with triamcinolone acetonide formulation after 3 months

July 27, 2016
A majority of patients treated with a proprietary form of triamcinolone acetonide in combination with aflibercept required no additional treatments…

July’s top five FDA news stories in ophthalmology

July 26, 2016
July’s hot topics in ophthalmology ranged from long-awaited FDA approvals including Shire’s lifitegrast ophthalmic solution for dry eye…

FDA raises concerns about manufacturing deficiencies in Dextenza complete response letter

July 25, 2016
Ocular Therapeutix received a complete response letter from the FDA regarding the new drug application for Dextenza for the treatment of…

Inotek receives US patent for trabodenoson, prostaglandin analogue for reduction of IOP

July 25, 2016
The United States Patent and Trademark Office has issued a composition of matter patent for trabodenoson in combination with a prostaglandin analogue…

Abbott second quarter worldwide sales increase to $5.3 billion

July 21, 2016
Abbott reported net sales of $5.3 billion in the second quarter, a 3.2% increase on a reported basis and a 6.4% increase on an operational basis from…

Novartis reports $12.5 billion in net sales in second quarter

July 20, 2016
Novartis reported $12.5 billion in net sales in the second quarter compared with $12.7 billion in the same quarter of 2015, according to a press…

Santen to acquire InnFocus

July 19, 2016
Santen Pharmaceutical announced it has entered into a definitive agreement to acquire InnFocus, developer of the MicroShunt glaucoma implant device…

GSRx launches eye wear line for independent practices

July 19, 2016
GSRx launched its Proper Optics Eyewear line of frames and lenses for independent practices as an affordable and quality option to maintain…

FDA approves Avedro’s cross-linking system for corneal ectasia following refractive surgery

July 19, 2016
The FDA has approved the KXL system and two photoenhancers for the treatment of corneal ectasia following refractive surgery, according to an Avedro…

More Headlines »